Calidi Biotherapeutics, Inc. (CLDI)
NYSEAMERICAN: CLDI · Real-Time Price · USD
0.2845
-0.0105 (-3.56%)
At close: Mar 24, 2026, 4:00 PM EDT
0.2801
-0.0044 (-1.55%)
After-hours: Mar 24, 2026, 4:12 PM EDT
Calidi Biotherapeutics Employees
Calidi Biotherapeutics had 28 employees as of December 31, 2024. The number of employees decreased by 13 or -31.71% compared to the previous year.
Employees
28
Change (1Y)
-13
Growth (1Y)
-31.71%
Revenue / Employee
n/a
Profits / Employee
-$915,000
Market Cap
2.04M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 28 | -13 | -31.71% |
| Dec 31, 2023 | 41 | 3 | 7.89% |
| Dec 31, 2022 | 38 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 49 |
| KALA BIO | 38 |
| HCW Biologics | 36 |
| Scinai Immunotherapeutics | 31 |
| BioRestorative Therapies | 11 |
| Ensysce Biosciences | 8 |
| Dermata Therapeutics | 8 |
| Onconetix | 5 |
CLDI News
- 12 days ago - Calidi Biotherapeutics Presents its Innovative and Scalable Manufacturing Process for CLD-401 at the 9th Annual Bioprocessing Summit; FDA Feedback Support Company's Approach to Manufacturing - GlobeNewsWire
- 14 days ago - Calidi Biotherapeutics Announces Closing of $6.0 Million Underwritten Public Offering and Full Exercise of Underwriters' Over-Allotment Option - GlobeNewsWire
- 18 days ago - Calidi Biotherapeutics Announces Pricing of $5.2 Million Underwritten Public Offering - GlobeNewsWire
- 18 days ago - Calidi Biotherapeutics Announces Proposed Public Offering - GlobeNewsWire
- 4 weeks ago - Calidi Biotherapeutics Presents Data on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform at the 2026 AACR-IO Conference - GlobeNewsWire
- 5 weeks ago - Calidi Biotherapeutics To Present on its New Approach to Bispecific T-Cell Engagers (BiTEs) Using its RedTail Platform in a Late-Breaking Abstract at the 2026 AACR-IO Conference - GlobeNewsWire
- 4 months ago - Calidi Biotherapeutics Announces Exclusive Live Investor Webinar and Q&A Session on November 19, 2025 - GlobeNewsWire
- 4 months ago - Calidi Biotherapeutics Reports Third Quarter 2025 Financial Results and Recent Operational Highlights - GlobeNewsWire